fluorobenzenes has been researched along with Venous Thrombosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Tian, JH; Yang, K; Zhang, P | 1 |
| Danielson, E; Fonseca, FA; Genest, J; Glynn, RJ; Gotto, AM; Kastelein, JJ; Koenig, W; Libby, P; Lorenzatti, AJ; MacFadyen, JG; Nordestgaard, BG; Ridker, PM; Shepherd, J; Willerson, JT | 1 |
| Choi, YJ; Han, SJ; Jo, SH; Kim, HS; Kim, SA; Park, WJ; Rhim, CY | 1 |
| Diaz, JA; Hawley, AE; Lawrence, DA; Myers, DD; Patterson, KA; Wakefield, TW; Wrobleski, SK; Zhang, X | 1 |
1 review(s) available for fluorobenzenes and Venous Thrombosis
| Article | Year |
|---|---|
Statins for primary prevention of venous thromboembolism.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Stroke; Sulfonamides; Venous Thromboembolism; Venous Thrombosis | 2014 |
2 trial(s) available for fluorobenzenes and Venous Thrombosis
| Article | Year |
|---|---|
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pulmonary Embolism; Pyrimidines; Risk; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism; Venous Thrombosis | 2009 |
Rationale and design of STOP DVT study: rosuvastatin for the prevention of deep vein thrombosis in patients undergoing total knee replacement arthroplasty--a prospective randomized open-label controlled trial.
Topics: Arthroplasty, Replacement, Knee; Drug Therapy, Combination; Enoxaparin; Fluorobenzenes; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Logistic Models; Orthopedic Procedures; Pyrimidines; Research Design; Risk Assessment; Rosuvastatin Calcium; Sample Size; Sulfonamides; Venous Thrombosis | 2011 |
1 other study(ies) available for fluorobenzenes and Venous Thrombosis
| Article | Year |
|---|---|
Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.
Topics: Animals; Apolipoproteins E; Cell Movement; Disease Models, Animal; Fluorobenzenes; Gene Deletion; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Inflammation; Interleukin-6; Male; Mice; Mice, Knockout; Neutrophils; P-Selectin; Pyrimidines; Rosuvastatin Calcium; Serpin E2; Sulfonamides; Thrombosis; Time Factors; Vena Cava, Inferior; Venous Thrombosis | 2013 |